These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11797239)

  • 1. Variant Creutzfeldt-Jakob disease (vCJD).
    Wkly Epidemiol Rec; 2001 Dec; 76(50):398-9. PubMed ID: 11797239
    [No Abstract]   [Full Text] [Related]  

  • 2. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG; Drohan W
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract]   [Full Text] [Related]  

  • 3. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
    Brandel JP; Peckeu L; Haïk S
    Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 5. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion.
    Wkly Epidemiol Rec; 2000 Nov; 75(47):377-9. PubMed ID: 11144617
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.
    Teljeur C; Flattery M; Harrington P; O'Neill M; Moran PS; Murphy L; Ryan M
    Transfusion; 2012 Nov; 52(11):2285-93. PubMed ID: 22486387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Peden AH; Ritchie DL; Ironside JW
    Folia Neuropathol; 2005; 43(4):271-8. PubMed ID: 16416391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion risk analysis with regard to vCJD in France].
    Martin M; Legras JF; Pouchol E; Trouvin JH
    Transfus Clin Biol; 2006 Nov; 13(5):298-303. PubMed ID: 17188540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
    Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
    Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BSE - A cause for Creutzfeldt- Jakob disease? ].
    Poser S
    Dtsch Med Wochenschr; 2002 Feb; 127(7):311. PubMed ID: 11845385
    [No Abstract]   [Full Text] [Related]  

  • 11. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases.
    Puopolo M; Ladogana A; Vetrugno V; Pocchiari M
    Transfusion; 2011 Jul; 51(7):1556-66. PubMed ID: 21214582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmissible spongiform encephalopathy update and implications for blood safety.
    Ricketts MN; Brown P
    Clin Lab Med; 2003 Mar; 23(1):129-37. PubMed ID: 12733428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment: dilemmas of dementia.
    Dodd RY
    J Clin Ethics; 2001; 12(2):141-2. PubMed ID: 11642065
    [No Abstract]   [Full Text] [Related]  

  • 14. vCJD and blood transfusion in the United Kingdom.
    Hewitt P
    Transfus Clin Biol; 2006 Nov; 13(5):312-6. PubMed ID: 17188541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to reduce transfusion acquired vCJD.
    Wallis JP
    Transfus Med; 2011 Feb; 21(1):1-6. PubMed ID: 21070399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Under pressure.
    Siddall R
    Health Serv J; 2003 Aug; 113(5869):12-3. PubMed ID: 12953390
    [No Abstract]   [Full Text] [Related]  

  • 17. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products.
    Millar CM; Makris M
    Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [vCJD epidemiology in France].
    Brandel JP; Salomon D; Alpérovitch A
    Transfus Clin Biol; 2006 Nov; 13(5):304-6. PubMed ID: 17188544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sensibility of safety: reflections on the Krever inquiry's final report.
    Hoey J
    CMAJ; 1998 Jan; 158(1):59-60. PubMed ID: 9475910
    [No Abstract]   [Full Text] [Related]  

  • 20. [Creutzfeldt-Jakob disease and transfusional risk: the point in 1998].
    Laperche S
    Transfus Clin Biol; 1999 Feb; 6(1):67-71. PubMed ID: 10188213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.